Cellular Electrophysiology and Molecular Biology, Institute for Genetics of Heart Diseases (IfGH), University Hospital Münster, Münster, Germany.
Cellular Electrophysiology and Molecular Biology, Institute for Genetics of Heart Diseases (IfGH), University Hospital Münster, Münster, Germany,
Cell Physiol Biochem. 2021 Nov 18;55(6):679-703. doi: 10.33594/000000470.
Viral diseases are a major threat to modern society and the global health system. It is therefore of utter relevance to understand the way viruses affect the host as a basis to find new treatment solutions. The understanding of viral myocarditis (VMC) is incomplete and effective treatment options are lacking. This review will discuss the mechanism, effects, and treatment options of the most frequent myocarditis-causing viruses namely enteroviruses such as Coxsackievirus B3 (CVB3) and Parvovirus B19 (PVB19) on the human heart. Thereby, we focus on: 1. Viral entry: CVB3 use Coxsackievirus-Adenovirus-Receptor (CAR) and Decay Accelerating Factor (DAF) to enter cardiac myocytes while PVB19 use the receptor globoside (Gb4) to enter cardiac endothelial cells. 2. Immune system responses: The innate immune system mediated by activated cardiac toll-like receptors (TLRs) worsen inflammation in CVB3-infected mouse hearts. Different types of cells of the adaptive immune system are recruited to the site of inflammation that have either protective or adverse effects during VMC. 3. Autophagy: CVB3 evades autophagosomal degradation and misuses the autophasomal pathway for viral replication and release. 4. Viral replication sites: CVB3 promotes the formation of double membrane vesicles (DMVs), which it uses as replication sites. PVB19 uses the host cell nucleus as the replication site and uses the host cell DNA replication system. 5. Cell cycle manipulation: CVB3 attenuates the cell cycle at the G1/S phase, which promotes viral transcription and replication. PVB19 exerts cell cycle arrest in the S phase using its viral endonuclease activity. 6. Regulation of apoptosis: Enteroviruses prevent apoptosis during early stages of infection and promote cell death during later stages by using the viral proteases 2A and 3C, and viroporin 2B. PVB19 promotes apoptosis using the non-structural proteins NS1 and the 11 kDa protein. 7. Energy metabolism: Dysregulation of respiratory chain complex expression, activity and ROS production may be altered in CVB3- and PVB19-mediated myocarditis. 8. Ion channel modulation: CVB3-expression was indicated to alter calcium and potassium currents in Xenopus laevis oocytes and rodent cardiomyocytes. The phospholipase 2-like activity of PVB19 may alter several calcium, potassium and sodium channels. By understanding the general pathophysiological mechanisms of well-studied myocarditis-linked viruses, we might be provided with a guideline to handle other less-studied human viruses.
病毒疾病是现代社会和全球卫生系统的主要威胁。因此,了解病毒如何影响宿主是寻找新的治疗方法的基础。病毒性心肌炎(VMC)的发病机制尚不完全清楚,也缺乏有效的治疗方法。本综述将讨论导致心肌炎的最常见病毒(如柯萨奇病毒 B3(CVB3)和细小病毒 B19(PVB19))对人类心脏的作用机制、影响和治疗选择。为此,我们重点讨论了以下几个方面:1. 病毒进入:CVB3 使用柯萨奇病毒-Adenovirus-Receptor(CAR)和衰变加速因子(DAF)进入心肌细胞,而 PVB19 使用受体Globoside(Gb4)进入心脏内皮细胞。2. 免疫系统反应:激活的心脏 Toll 样受体(TLRs)介导的固有免疫系统使 CVB3 感染小鼠心脏的炎症恶化。不同类型的适应性免疫系统细胞被招募到炎症部位,它们在 VMC 中既有保护作用也有不良影响。3. 自噬:CVB3 逃避自噬小体降解并滥用自噬小体途径进行病毒复制和释放。4. 病毒复制部位:CVB3 促进双膜囊泡(DMVs)的形成,它将其用作复制部位。PVB19 使用宿主细胞细胞核作为复制部位,并利用宿主细胞 DNA 复制系统。5. 细胞周期操纵:CVB3 在 G1/S 期减弱细胞周期,从而促进病毒转录和复制。PVB19 使用其病毒内切核酸酶活性在 S 期使细胞周期停滞。6. 细胞凋亡的调节:肠道病毒在感染早期阻止细胞凋亡,并通过使用病毒蛋白酶 2A 和 3C 以及 viroporin 2B 在后期促进细胞死亡。PVB19 使用非结构蛋白 NS1 和 11 kDa 蛋白促进细胞凋亡。7. 能量代谢:CVB3 和 PVB19 介导的心肌炎可能改变呼吸链复合物表达、活性和 ROS 产生的失调。8. 离子通道调节:CVB3 表达被表明改变 Xenopus laevis 卵母细胞和啮齿动物心肌细胞中的钙和钾电流。PVB19 的磷脂酶 2 样活性可能改变几种钙、钾和钠通道。通过了解研究较好的心肌炎相关病毒的一般病理生理机制,我们可能会得到一个处理其他研究较少的人类病毒的指导方针。